Regeneron Pharmaceuticals, Inc. (ETR:RGO)
495.40
+3.10 (0.63%)
At close: Oct 10, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €50.37 billion as of October 10, 2025. Its market cap has decreased by -49.50% in one year.
Market Cap
50.37B
Enterprise Value
37.61B
Revenue
12.10B
Ranking
n/a
PE Ratio
13.27
Stock Price
€495.40
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 50.37B, an increase of 38,227.37%. That is a compound annual growth rate of 19.59%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 50.37B | -31.96% |
Dec 31, 2024 | 74.03B | -12.40% |
Dec 29, 2023 | 84.50B | 17.20% |
Dec 30, 2022 | 72.10B | 24.19% |
Dec 31, 2021 | 58.06B | 39.28% |
Dec 31, 2020 | 41.68B | 13.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.50B |
Siemens Aktiengesellschaft | 187.82B |
Deutsche Telekom AG | 141.42B |
Allianz SE | 139.73B |
Siemens Energy AG | 90.31B |
Rheinmetall AG | 86.35B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 72.92B |
Deutsche Bank Aktiengesellschaft | 57.47B |